“The market concentration trend is only natural, it will continue, the interest in acquisitions is high, because we have to catch up in terms of pharmaceutical consumption. I think the pharmaceutical market will double in ten years, and the medical service market will triple,” Mihai Miron told ZF.
Ropharma is the fifth largest actor on the local pharmacy market and posted 490 million lei (over EUR100 million) revenue last year. It operates 140 pharmacies, according to the latest data available.
The local pharmaceutical market has become attractive to foreign investors, as shown by recent deals. Czech Republic’s Penta investments bought A&D Pharma group, which includes Sensiblu, and Germany’s Phoenix bought the Farmexim group, which includes Help Net retail pharmacy chain.
(English version by Loredana Fratila-Cristescu)